Biomarkers in DILI: One More Step Forward - Wikidata - awgldk - TriplyDB

Biomarkers in DILI: One More Step Forward

Biomarkers in DILI: One More Step Forward

http://www.wikidata.org/entity/Q28071799

about

Role of circulating microRNAs in liver diseases Metabolomic approaches in the discovery of potential urinary biomarkers of drug-induced liver injury (DILI).Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury.Genetic Factors Influencing Drug-Induced Liver Injury: Do They Have a Role in Prevention and Diagnosis?HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicity The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity.MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury.Increased circulating microRNA-122 is associated with mortality and acute liver injury in the acute respiratory distress syndrome.Proteomics Analysis of Monocyte-Derived Hepatocyte-Like Cells Identifies Integrin Beta 3 as a Specific Biomarker for Drug-Induced Liver Injury by Diclofenac

P2860

Q38779843-A5027DC5-939C-46D3-BD7E-18043345FA4A Q39258217-B4CD51A9-9618-403F-9BFE-3EC4148F8FE4 Q39366146-C7F166E1-7DD8-470B-9C7F-514EF0F2A277 Q41389082-8C3C6D0E-30D3-4E0A-9523-98F51918F228 Q42362078-F82A5FB8-79F0-410B-B328-A48DE7B33B4C Q47553075-D48F13B9-565B-46EE-8BBD-5B8FBD1A06CA Q49862111-74C1190C-4198-49AB-AD5E-B8CA4851C6F5 Q55500120-BE7833C4-A046-48A5-A224-DB0E6DDFBF83 Q57177177-52A03EE1-FF26-46B8-9A95-0E5FF582B5C6

P2860

Biomarkers in DILI: One More Step Forward

http://www.wikidata.org/entity/Q28071799

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Biomarkers in DILI: One More Step Forward

@ast

Biomarkers in DILI: One More Step Forward

@en

Biomarkers in DILI: One More Step Forward

@nl

type

label

Biomarkers in DILI: One More Step Forward

@ast

Biomarkers in DILI: One More Step Forward

@en

Biomarkers in DILI: One More Step Forward

@nl

prefLabel

Biomarkers in DILI: One More Step Forward

@ast

Biomarkers in DILI: One More Step Forward

@en

Biomarkers in DILI: One More Step Forward

@nl

P1433

Q28071799-5711883D-A65D-4B51-BEE8-23DCAE1DA2D6

P1476

Q28071799-FA174C70-E8ED-45D9-A268-71D8008D0C40

P2093

Q28071799-0EF8450C-152C-4EAF-861C-84678B14BDFE

Q28071799-C28979B9-BD54-482F-915C-6C3F18EEF141

Q28071799-D6D1B008-80C2-40CB-9F0F-27A5DA21AAA6

Q28071799-F13DF86C-A891-4EE8-B771-6BB21759267C

P2860

Q28071799-0C44A3DF-67C1-47E9-B9FD-157BE7DA8D20

Q28071799-0E62E640-740E-4FED-ADF0-075363BEE5D5

Q28071799-0E865432-8C94-433E-A81E-A9B493134FAA

Q28071799-120AE1E4-0937-40DE-A427-4B66819F9FF7

Q28071799-14EAA173-C097-4DC5-85BC-331CF6826923

Q28071799-1B6F648B-C23A-4EBB-8B2E-0AAFC5AC5A8B

Q28071799-1BDC0071-1554-434C-9178-93653084F7DD

Q28071799-211ECCB1-0FEC-4BB2-88AD-86CD580DF6F7

Q28071799-23109A8C-1BAD-472A-9EBE-ED463E24FC46

Q28071799-232FC5A2-FB6E-48F9-8149-39C9592C4BA7

P304

Q28071799-E302EE8A-350A-481B-AB74-38A2CF65C8FD

P31

Q28071799-712B5140-64C0-4765-9272-10FC14EAB5AD

P3181

Q28071799-99899A4E-4474-40DC-BBF3-F5CD9965B189

P356

Q28071799-C59088FD-19BD-4562-B848-7C216F910371

P407

Q28071799-AAC76749-FE47-40AD-AA43-284311405217

P478

Q28071799-A34F0934-BB1E-4754-A333-9E4AF48C3B78

P50

Q28071799-C0E8CD8D-0C27-41AB-A4DF-62B767903C24

P577

Q28071799-E6C57E0F-59F8-4337-AE05-01F31141FCFB

P698

Q28071799-F09F72AC-CC2A-4062-B5CA-7EE02B93FECD

P921

Q28071799-A8FDB799-D96C-4968-A049-895B827B3508

P932

Q28071799-DF23E0B1-5DE5-4558-8953-0F3DCF8A3439

P3181

P356

FPHAR.2016.00267

P1433

Frontiers in Pharmacology

P1476

Biomarkers in DILI: One More Step Forward

@en

P2093

Camilla Stephens

http://www.w3.org/2001/XMLSchema#string

Inmaculada Medina-Caliz

http://www.w3.org/2001/XMLSchema#string

M Isabel Lucena

http://www.w3.org/2001/XMLSchema#string

Raúl J Andrade

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of metabolites, clinical chemistry markers and transcripts associated with hepatotoxicity

Circulating microRNAs, potential biomarkers for drug-induced liver injury

Identification of tissue-specific microRNAs from mouse

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury

Detection of the mitochondrial and catalytically active alanine aminotransferase in human tissues and plasma

Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

The metabolomic window into hepatobiliary disease.

Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity

P304

267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3950123

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FPHAR.2016.00267

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Mercedes Robles-Diaz

P577

2016-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27597831

http://www.w3.org/2001/XMLSchema#string

P921

P932

4992729

http://www.w3.org/2001/XMLSchema#string